The genetics of hypogammaglobulinemia

Current Allergy and Asthma Reports

Volumn 4, Issue 5, 2004, Pages 349-358

  Grimbacher, Bodo ^a   Schäffer, Alejandro A ^a   Peter, Hans Hartmut ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE ANTIBODY; CAPTOPRIL; CARBAMAZEPINE; CHLOROQUINE; CORTICOSTEROID; CYTOTOXIC AGENT; FENCLOFENAC; GOLD; HYDANTOIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PENICILLAMINE; POLYSACCHARIDE VACCINE; SALAZOSULFAPYRIDINE; VALPROIC ACID; ZONISAMIDE;

ATAXIA TELANGIECTASIA; COMMON VARIABLE IMMUNODEFICIENCY; DIGEORGE SYNDROME; DISEASE CLASSIFICATION; GENETIC SUSCEPTIBILITY; HUMAN; HUMORAL IMMUNE DEFICIENCY; HYPOGAMMAGLOBULINEMIA; IMMUNOGLOBULIN A DEFICIENCY; IMMUNOGLOBULIN G DEFICIENCY; INFANT DISEASE; LINKAGE ANALYSIS; MOLECULAR GENETICS; REVIEW; WISKOTT ALDRICH SYNDROME;

EID: 4544256919     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-004-0083-4     Document Type: Review

References (90)

1. Nahm MH, Scott MC, Shackleford PC: Expression of human IgG subclasses. Ann Clin Lab Sci 1987, 17:183-196.
2. Rijkers GT, Sanders LAM, Zegers BJM: Anti-capsular polysaccharide antibody deficiency states. Immunodeficiency 1993, 5:1-21.
3. Kruetzmann S, Rosado MM, Weber H, et al.: Human immunoglobulin M memory B cells controlling infections are generated in the spleen. J Exp Med 2003, 197:939-945.
4. Conley ME: Genetics of primary immunodeficiency diseases. Rev Immunogenet 2000, 2:231-242.
5. International Union of Immunological Societies (IUIS): Primary immunodeficiency diseases: report of an IUIS Scientific Committee. Clin Exp Immunol 1999, 118 (Suppl 1): 1-28.
6. Schauer U, Stemberg F, Rieger CHL, et al.: IgG subclass concentrations in certified reference matieral 470 and reference values for children and adults determined wit the binding site reagents. Clin Chem 2003a,49:1925-1929
7. Lorber A, Simon T, Leeb J, et al.: Chrysotherapy: suppression of immunoglobulin synthesis. Arthritis Rheum 1978, 5:785-791.
8. Snowden N, Dietsch DM, Teh LS, et al.: Antibody deficiency associated with gold treatment: natural history and management in 22 patients. Ann Rheum Dis 1996, 55:616-621.
9. Hanson L, Björkander J, Robbins JB, et al.: IgG subclass deficiencies. Vox Sang 1986, 51 (Suppl 2):50-56.
10. Buckley RH: Immunoglobulin G subclass defidency: fact or fancy. Curr Allergy Asthma Rep 2002, 2:356-360.
11. Pan Q, Hammarström L: Molecular basis of IgG subclass deficiency. Immunol Rev 2000, 178:99-110.
12. Lefranc M-P, Hammarström L, Smith CIE, Lefranc G: Gene deletions in the immunoglobulin heavy chain constant region locus: molecular and immunological analysis. Immunodefic Rev 1991, 2:265-281.
13. Hammarström L, Carbonara AO, DeMarchi M, et al.: Generation of the antibody repertoire in individuals with multiple immunoglobulin heavy chain constant region gene deletions. Scand J Immunol 1987, 25:189-194.
14. Lefranc M-P, Lefranc G, Rabbitts TH: Inherited deletion of immunoglobulin heavy chain constant region genes in normal human individuals. Nature 1982, 300:760-762.
15. Schauer U, Stemberg F, Rieger CHL, et al.: Levels of antibodies specific to tetanus toxoid, Haemophilus influenzae type B, and pneumococcal capsular polysaccharide in healthy children and adults. Clin Diagn Lab Immunol 2003b, 10:202-207.
16. Sorensen RU, Leiva LE, Javier FC, et al.: Influence of age on the response to Streptococcus pneumoniae vaccine in patients with recurrent infections and normal immunoglobulin concentrations. J Allergy Clin Immunol 1998a, 102:215-221.
17. Hidalgo H, Mooer C, Leiva LE, Sorensen RU: Preimmunisation and postimmunisation pneumococcal antibody titers in children with recurrent infections. Ann Allergy Asthma Immunol 1996, 76:341-346.
18. Sorensen RU, Leiva LE, Giangrosso PA, et al.: Response to heptavalent conjugate Streptococcus pneumoniae vaccine in children with recurrent infections who are unresponsive to the polysaccharide vaccine. Pediatr Infect Dis 1998, 17:685-691.
19. Dalal I, Reid B, Nisbet-Brown E, Roifman CM: The outcome of patients with hypogamma-globulinemia in infancy and early childhood. J Pediatr 1998, 133:144-146.
20. Dressler F, Peter HH, Müller W, Rieger CHL: Transient hypogammaglobulinemia of infancy. Acta Paediatr Scand 1989, 78:767-774.
21. Stiehm ER: Transient hypogammaglobulinemia of infancy. In Immunologic Disorders in Infants and Children, edn 4. Philadelphia: W.B. Saunders; 1996:284-285.
22. Chapel H, Geha R, Rosen FS, for the IUIS PID Classification Committee: Primary imunodeficiency disease: an update. Clin Exp Immunol 2003, 132:9-15.
23. Pfluger H, Helbling A, Mordasini C, Pichler WJ: CVID (common variable immunodeficiency): heterogene Krankheitsmanifestation dieses häufigsten symptomatischen primären Immundefekts. Schweiz Med Wochenschr 2000, 130:1590-1599.
24. Burrows PD, Cooper MD: IgA deficiency. Adv Immunol 1997, 65:245-276.
25. Hammarström L, Vorechovský I, Webster D: Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID). Clin Exp Immunol 2000, 120:225-231.
26. Español T, Catala M, Hernandez M, Caragol I, Bertran JM: Development of a common variable immunodeficiency in IgA-deficient patients. Clin Immunol Immunopathol 1996, 80:333-335.
27. Carvalho Neves forte W, Ferreira De Carvalho Junior F, Damaceno N, et al.: Evolution of IgA deficiency to IgG subclass deficiency and common variable immunodeficiency. Allergol Immunopathol (Madr) 2000, 28:18-20.
28. Johnson ME, Keeton LG, Zhu ZB, et al.: Age-related changes in serum immunoglobulins in patients with familial IgA deficiency and common variable immunodeficiency (CVID). Clin Exp Immunol 1997, 108:477-483.
29. Cunningham-Rundles C: Clinical and immunologic analyses of 103 patients with common variable immunodeficiency. J Clin Immunol 1989, 9:22-33.
30. Cunningham-Rundles C, Bodian C: Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 1999, 92:34-48.
31. Cunningham-Rundles C: Common variable immunodeficiency. Curr Allergy Asthma Rep 2001, 1:421-429.
32. Sneller MC: Common variable immunodeficiency. Am J Med Sci 2001, 321:42-48.
33. Vorechovský I, Zetterquist H, Paganelli R, et al.: Family and linkage study of selective IgA deficiency and common variable immunodeficiency. Clin Immunol Immunopathol 1995, 77:185-192.
34. Nijenhuis T, Klasen I, Weemaes C, et al.: Common variable immunodeficiency (CVID) in a family: an autosomal dominant mode of inheritance. Neth J Med 2001, 59:134-139.
35. Braig DU, Schäffer AA, Glocker E, et al.: Linkage of autosomal dominant common variable immunodeficiency to chromosome 5p and evidence for locus heterogeneity. Hum Genet 2003, 112:369-378.
36. Grimbacher B, Hutloff A, Schlesier M, et al.: Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nature Immunol 2003, 4:261-268.
37. Vorechovský I, Litzman J, Lokaj J, Sobotková R: Family studies in common variable immunodeficiency. J Hyg Epidemiol Microbiol Immunol 1991, 35:17-26.
38. Vorechovský I, Cullen M, Carrington M, et al.: Fine mapping of IGAD1 in IgA deficiency and common variable immunodeficiency: identification and characterization of haplotypes shared by affected members of 101 multiple-case families. J Immunol 2000, 164:4408-4416.
39. Kralovicova J, Hammarström L, Plebani A, et al.: Fine-scale mapping at IGAD1 and genome-wide genetic linkage analysis implicate HLA-DQ/DR as a major susceptibility locus in selective IgA deficiency and common variable immunodeficiency. J Immunol 2003, 170:2765-2775.
40. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES: Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet 1996, 58:1347-1363.
41. Schaffer FM, Palermos J, Zhu ZB, et al.: Individuals with IgA deficiency and common variable immunodeficiency share polymorphisms of major histocompatibility complex class III genes. Proc Nat Acad Sci U S A 1989, 86:8015-8019.
42. Olerup O, Smith CIE, Hammarström L: Different amino acids at position 57 of the HLA-DQ beta chain associated with susceptibility and resistance to IgA deficiency. Nature 1990, 347:289-290.
43. Olerup O, Smith CI, Bjorkänder J, Hammarström L: Shared HLA class II-associated genetic susceptibility and resistance, related to the HLA-DQB1 gene, in IgA deficiency and common variable immunodeficiency. Proc Natl Acad Sci U S A 1992, 89:10653-10657.
44. Volanakis JE, Zhu ZB, Schaffer FM, et al.: Major histocompatibility complex class III genes and susceptibility to immunoglobulin A deficiency and common variable immunodeficiency. J Clin Invest 1992, 89:1914-1922.
45. Cucca F, Zhu Z-B, Khanna A, et al.: Evaluation of IgA deficiency in Sardinians indicates a susceptibility gene is encoded within the HLA class III region. Clin Exp Immunol 1998, 111:76-80.
46. Schroeder HW Jr, Zhu ZB, March RE, et al.: Susceptibility locus for IgA deficiency and common variable immunodeficiency in the HLA-DR3, -B8, -A1 haplotypes. Mol Med 1998, 4:72-86.
47. Vorechovský I, Webster ADB, Plebani A, Hammarström L: Genetic linkage of IgA deficiency to the major histocompatibility complex: evidence for allele segregation distortion, parent-of-origin penetrance differences, and the role of anti-IgA antibodies in disease predisposition. Am J Hum Genet 1999, 64:1096-1109.
48. Vorechovský I, Webster ADB, Hammarström L: Mapping genes underlying complex disorders: progress on IgA deficiency and common variable immunodeficiency. Adv Exp Med Biol 2001, 495:183-190.
49. De la Concha LG, Fernandez-Arquero M, Gual L, et al.: MHC susceptibility genes to IgA deficiency are located in different regions on different HLA haplotypes. J Immunol 2002, 169:4637-4643.
50. Terwilliger JD, Ott J: Handbook of Human Genetic Linkage. Baltimore: Johns Hopkins University Press; 1994.
51. North ME, Spickett GP, Allsop J, et al.: Defective DNA synthesis by T cells in acquired 'common-variable' hypogammaglobulinaemia on stimulation with mitogens. Clin Exp Immunol 1989, 76:19-23.
52. Pastorelli G, Roncarolo MG, Touraine JL, et al.: Peripheral blood lymphocytes of patients with common variable immunodeficiency (CVI) produce reduced levels of interleukin-4, interleukin-2 and interferon-g, but proliferate normally upon activation by mitogens. Clin Exp Immunol 1989, 78:334-340.
53. Sneller MC, Strober W: Abnormalities of lymphokine gene expression in patients with common variable immunodeficiency. J Immunol 1990, 144:3762-3769.
54. Rump JA, Jahreis A, Schlesier M, et al.: Possible role of IL-2 deficiency for hypogammaglobulinaemia in patients with common variable immunodeficiency. Clin Exp Immunol 1992, 89:204-210.
55. Farrington M, Grosmaire LS, Nonoyama S, et al.: CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency. Proc Natl Acad Sci U S A 1994, 91:1099-1103
56. Fischer MB, Wolf HM, Hauber I, et al.: Activation via the antigen receptor is impaired in T cells, but not in B cells from patients with common variable immunodeficiency. Eur J Immunol 1996, 6:231-237.
57. Zhang J-G, Morgan L, Spickett GP: L-selectin in patients with common variable immunodeficiency (CVID): a comparative study with normal individuals. Clin Exp Immunol 1996, 104:275-279.
58. Pozzi N, Gaetaniello L, Martire B, et al.: Defective surface expression of attraction on T cells in patients with common variable immunodeficiency (CVID). Clin Exp Immunol 2001, 123:99-104.
59. Fischer MB, Ma M, Goerg S, et al.: Regulation of the B cell response to T-dependent antigens by classical pathway complement. J Immunol 1996, 157:549-556.
60. Thon V, Eggenbauer H, Wolf HM, et al.: Antigen presentation by common variable immunodeficiency (CVID) B cells and monocytes is unimpaired. Clin Exp Immunol 1997, 108: 1-8.
61. Boncristiano M, Majolini MB, D'Elios MM, et al.: Defective recruitment and activation of ZAP-70 in common variable immunodeficiency patients with T cell defects. Eur J Immunol 2000, 30:2632-2638.
62. Kondratenko I, Amlot PL, Webster ADB, Farrant J: Lack of specific antibody response in common variable immunodeficiency (CVID) associated with failure in production of antigen-specific memory T cells. Clin Fxp Immunol 1997, 108:9-13.
63. Jaffe JS, Eisenstein E, Sneller MC, Strober W: T-cell abnormalities in common variable immunodeficiency. Pediatr Res 1993, 33:S24-27; discussion S27-28.
64. Saiki O, Ralph P, Cunningham-Rundles C, Good RA: Three distinct stages of B-cell defects in common varied immunodeficiency. Proc Natl Acad Sci U S A 1982, 79:6008-6012.
65. Eisenstein EM, Strober W: Evidence for a generalized signaling abnormality in B cells from patients with common variable immunodeficiency. Adv Exp Med Biol 1995, 371B:699-704.
66. Levy I, Gupta N, Le Deist F, Garcia C: Defect in IgV gene somatic hypermutation in common variable immunodeficiency syndrome. Proc Natl Acad Sci U S A 1998, 95:13135-13140.
67. Denz A, Eibel H, Illges H, et al.: Impaired upregulation of CD86 in B cells of "type A" common variable immunodeficiency patients. Eur J Immunol 2000, 30:1069-1077.
68. Brouet J-C, Chedeville A, Fermand J-P, Royer B: Study of the B cell memory compartment in common variable immunodeficiency. Eur J Immunol 2000, 30:2516-2520.
69. Jacquot S, Maçon-Lemaître Lank E, et al.: B cell co-receptors regulating T cell-dependent antibody production in common variable immunodeficiency: CD27 pathway defects identify subsets of severely immuno-compromised patients. Int Immunol 2001, 13:871-876.
70. Warnatz K, Denz A, Dräger R, et al.: Severe deficiency of switched memory B cells (CD27+IgM-IgD-) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood 2002, 99:1544-1551.
71. Spickett GP, Farrant J, North ME, et al.: Common variable immunodeficiency: how many diseases? Immunol Today 1997, 18:325-328.
72. Bryant A, Calvet NC, Toubi E, et al.: Classification of patients with common variable immunodeficiency by B cell secretion of IgM and IgG in response to anti-IgM and interieukin-2. Clin Immunol Immunopathol 1990, 56:239-248.
73. Greer JP, Kinney MC, Loughran TP: T cell and NK cell lymphoproliferative disorders. In "Hematology 2001 " American Society of Hematology Education Program Book. Edited by Schechter CP, Broudy VC, Wiliams ME. 2001:259-281.
74. Baumert E, Wolff-Vorbeck G, Schlesier M, Peter HH: Immunophenotypical alterations in a subset of patients with common variable immunodeficiency (CVID). Clin Exp Immunol 1992, 90:25-30.
75. Loder F, Mutschler B, Ray RJ, et al.: B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J Exp Med 1999, 190:35-89.
76. Fischer MB, Goerg S, Shen L, et al.: Dependence of germinal center B cells on the expression of CD21/CD35 for survival. Science 1998, 280:582-585.
77. Caroll MC: The role of complement in B cell activation and tolerance. Adv Immunol 2000, 2:1089-1090.
78. Masilamani M, Kassahn D, Mikkat S, et al.: B cell activation leads to shedding of complement receptor type II (CR2/CD21). Eur J Immunol 2003, 33:2391-2397.
79. Herbst EW, Armbruster M, Rump J-A, et al.: Intestinal B cell defects in common variable immunodeficiency. Clin Exp Immunol 1994, 95:215-221.
80. Artus U, Herbst EW, Rump JA, Peter HH: Defekte der immunglobulinbilenden Zellen im Knochenmark von Patientem mit variablem Immundefektsyndrom. Immun Injekt 1995, 23:69-71.
81. Sawada A, Takihara Y, Kim JY, et al.: A congenital mutation of the novel gene LRRC8 causes agammaglobulinemia in humans. J Clin Invest 2003, 112:1707-1713.
82. Tsukada S, Saffran DC, Rawlings DJ, et al.: Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-liked agammaglobulinemia. Cell 1993, 72:279-290.
83. Vetrie D, Vorechovský I, Sideras P, et al.: The gene involved in X-linked agammaglobulinemia is a member of the src family of protein-tyrosine kinases. Nature 1993, 361:226-233.
84. Conley ME, Mathias D, Treadaway J, et al.: Mutations in Btk in patients with presumed X-linked agammaglobulinemia. Am J Hum Genet 1998, 62:1034-1043.
85. Yel L, Minegishi Y, Coustan-Smith E, et al.: Mutations in the mu heavy-chain gene in patients with agammaglobulinemia. N Engl J Med 1996, 335:1486-1493.
86. Meffre E, Milili M, Blanco-Betancourt C, et al.: Immunoglobulin heavy chain expression shapes the B cell receptor repertoire in human B cell development. J Clin Invest 2001, 108:879-886.
87. Lopez Granados E, Porpiglia AS, Hogan MB, et al.: Clinical and molecular characterization of patients with defects in mu heavy chain gene. J Clin Invest 2002, 110:1029-1035.
88. Minegishi Y, Coustan-Smith F, Rapalus L, et al.: Mutations in Ig-alpha (CD79a) result in a complete block in B-cell development. J Clin Invest 1999a, 104:1115-1121.
89. Minegishi Y, Rohrer J, Coustan-Smith E, et al.: An essential role for BLNK in human B cell development. Science 1999b, 286:1954-1957.
90. Minegishi Y, Coustan-Smith E, Wang Y-H, et al.: Mutations in the human lambda-5/14.1 gene result in B cell deficiency and agammaglobulinemia. J Exp Med 1998, 187:71-77.